Pharvaris N.V.
PHVS
$32.94
$1.695.41%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.79% | -13.57% | 0.33% | 11.51% | 60.54% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.28% | 11.29% | 23.82% | 44.44% | 64.26% |
| Operating Income | -15.28% | -11.29% | -23.82% | -44.44% | -64.26% |
| Income Before Tax | -46.85% | 4.33% | -60.96% | -60.92% | -3.72% |
| Income Tax Expenses | 46.64% | -183.87% | 202.76% | 2.91% | 64.09% |
| Earnings from Continuing Operations | -46.84% | 5.32% | -61.30% | -60.33% | -5.10% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -46.84% | 5.32% | -61.30% | -60.33% | -5.10% |
| EBIT | -15.28% | -11.29% | -23.82% | -44.44% | -64.26% |
| EBITDA | -15.25% | -11.28% | -23.92% | -44.63% | -64.23% |
| EPS Basic | -22.49% | 17.77% | -59.08% | -58.16% | 14.49% |
| Normalized Basic EPS | -22.50% | 16.90% | -58.77% | -58.73% | 15.62% |
| EPS Diluted | -22.49% | 17.77% | -59.08% | -58.16% | 14.49% |
| Normalized Diluted EPS | -22.50% | 16.90% | -58.77% | -58.73% | 15.62% |
| Average Basic Shares Outstanding | 19.88% | 15.14% | 1.39% | 1.38% | 22.91% |
| Average Diluted Shares Outstanding | 19.88% | 15.14% | 1.39% | 1.38% | 22.91% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |